- 2 - 
In anticipation of the possible need for additional legislation to implement 
such registration and regulation, 1 would appreciate it if you would furnish the 
following information by March 15, 1977. 
1. Is your company or institution engaged, or has it previously been engaged, 
in the conduct or support of recombinant DMA research in the United States or elsewhere? 
If so, please provide information concerning the nature and location of such research and 
identity of the company or institution conducting such research. Also please furnish the 
same information about any contemplated research of this kind. 
2. If your company or institution has not engaged in recombinant DKA research, 
is such research being contemplated? If so, please provide the nature and location of 
such research and the identity of the company or institution which will conduct the 
research. 
3. If recombinant DNA research is being conducted or contemplated, is your 
company or institution willing to register such research and comply with the Mill guide- 
lines? 
4. If your company or institution can not comply with the Kill guidelines, what 
changes in the guidelines would you suggest to make compliance possible? 
5. has your company or institution obtained any patents for recombinant DNA? 
If so, please furnish information concerning the nature of the patents and the dates they 
were issued. 
Your cooperation in this important matter will be very much appreciated. 
[ 230 ] 
